November 25th 2024
Fluorescence spectroscopy offers unique advantages for characterizing EVs.
September 5th 2024
Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.
July 12th 2024
With the acquisition, Olink will join Thermo Fisher’s Life Sciences Solutions business.
June 6th 2024
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
June 5th 2024
Biosimilar analytical assessments focus on demonstrating biosimilarity and interchangeability with the reference biologic.